Indus Biotech Private Limited Patent applications |
Patent application number | Title | Published |
20160113897 | METHOD OF MANAGING HEPATIC FIBROSIS, HEPATITIS C VIRUS AND ASSOCIATED CONDITION - The present disclosure relates to management of Hepatitis C Virus (HCV) and associated condition. The present disclosure also relates to management of Hepatic Fibrosis. The present disclosure relates to administration of composition comprising pentameric type A procyanidin, trimeric procyanidin and tetrameric procyanidin, optionally along with pharmaceutically acceptable excipient, for management of Hepatic Fibrosis, Hepatitis C virus and associated conditions. The composition acts as an inhibitor at the entry stage of Hepatitis C virus into a cell. The composition inhibits different genotypes of Hepatitis C Virus. | 04-28-2016 |
20160082027 | A COMPOSITION FOR TREATING NEUROPATHY, A PROCESS AND A METHOD OF TREATMENT THEREOF - The present disclosure relates to a composition comprising eleutheroside-C, pinitol and sugars optionally along with pharmaceutically acceptable excipient or a combination thereof; a process of obtaining said composition from fenugreek seeds, a method of treating neuropathic pain or managing neuropathy, and the use of the said composition in treating neuropathic pain or managing neuropathy. | 03-24-2016 |
20140187624 | METHOD OF MANAGING CHEMOTHERAPY INDUCED ALOPECIA OR CACHEXIA OR BOTH - The present disclosure is related to management of chemotherapy induced side effects namely cachexia and alopecia by administering a pharmaceutical composition comprising pentameric type A procyanidin flavonoid, trimeric procyanidin flavonoid and tetrameric procyanidin flavonoid, optionally along with pharmaceutical excipients. | 07-03-2014 |
20130089605 | Method for Preparation of Highly Pure Asiaticoside Composition from Centella Asiatica and a Method of Use Thereof - Disclosed is a commercially viable asiaticoside composition having at least 99% purity that is derived from plant | 04-11-2013 |
20120282332 | COMPOSITION AND METHOD THEREOF - The present disclosure relates to a composition comprising Trigoneoside Ib and Vicenin-1 for treatment and management of Goodpasture's disease, Glomerulonephritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus and Idiopathic Thrombocytopenia Purpura. The present disclosure also relates to a method of obtaining the said composition from | 11-08-2012 |
20120148504 | COMPLEX OF GARCINOL, CYCLODEXTRIN AND METHOD THEREOF - The present disclosure discloses a pharmaceutical molecule of Garcinol chemically complexed with cyclodextrins and the use of the complexed molecule in prevention and management of cardiac dysfunction induced by chemotherapy, drugs and/or other insults to the heart caused by lifestyle and disease conditions. The disclosure also relates to a method of extraction and purification of high yield of 95-99% pure Garcinol from | 06-14-2012 |
20110039923 | NOVEL STANDARDIZED COMPOSITION, METHOD OF MANUFACTURE AND USE IN THE RESOLUTION OF RNA VIRUS INFECTION - The present disclosure is in relation to antiviral preparations obtained from plant sources namely Cinnamon, | 02-17-2011 |
20090281057 | Botanically Derived Composition and a Process Thereof - The present invention relates to a novel botanical compound as provided in structural formula I optionally along with excipients for improving body composition and the factors related to the pre-diabetic and diabetic conditions. It also relates to a process of manufacture of the novel botanical compound for improving body composition and factors related to the pre-diabetic and diabetic conditions. The present invention also relates to the use of the novel botanical compound for improving body composition, reducing body fat, increasing muscle mass, enhancing strength and improving impaired glucose metabolism. The present invention also relates to the use of the novel botanical compound for the improvement of factors related to the pre-diabetic and diabetic conditions. | 11-12-2009 |